Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Condition:   SARS-CoV-2 Infection Intervention:   Biological: B/HPIV3/S-6P Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Johns Hopkins Bloomberg School of Public Health;   National Institutes of Health (NIH) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials